It consists of three parts: (a) a miRNA mimic based on miR-16, as several different forms of cancer have been linked to the miR-16 family’s role as tumor suppressors [234]; (b) a drug delivery system called EnGeneIC Dream Vector (EDV), where EDVs are non-living bacterial mini-cells (nanoparticles) that enable the efficient packaging of drugs, proteins, or nucleic acids inside them; (c) as a targeting moiety, an anti-epidermal growth factor receptor (EGFR) antibody that directs the EDVs to cancer cells expressing EGFR [225,233]. The gene discussed is EGFR; the disease is cancer.